Patents by Inventor DeAnna ADKINS

DeAnna ADKINS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating central nervous system injury
    Patent number: 11806389
    Abstract: The present invention describes compositions and method for improving outcomes after injury to the central nervous system wherein complement signaling is activated. In one aspect, the method comprises administering to a subject a therapeutically effective amount of a therapeutic agent comprising a targeted inhibitor molecule comprising a targeting portion and an inhibitor portion, wherein the molecule inhibits complement, and wherein therapeutic agent is administered in combination with rehabilitation therapy or thrombolytic agent.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: November 7, 2023
    Assignees: MUSC Foundation For Research Development, United States Government as Represented by the Department of Veteran Affairs
    Inventors: Stephen Tomlinson, DeAnna Adkins, Ali Alawieh
  • COMPOSITIONS AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM INJURY
    Publication number: 20210369823
    Abstract: The present invention describes compositions and method for improving outcomes after injury to the central nervous system wherein complement signaling is activated. In one aspect, the method comprises administering to a subject a therapeutically effective amount of a therapeutic agent comprising a targeted inhibitor molecule comprising a targeting portion and an inhibitor portion, wherein the molecule inhibits complement, and wherein therapeutic agent is administered in combination with rehabilitation therapy or thrombolytic agent.
    Type: Application
    Filed: May 14, 2021
    Publication date: December 2, 2021
    Inventors: Stephen Tomlinson, DeAnna Adkins, Ali Alawieh
  • Compositions and methods for treating central nervous system injury
    Patent number: 11007254
    Abstract: The present invention describes compositions and method for improving outcomes after injury to the central nervous system wherein complement signaling is activated. In one aspect, the method comprises administering to a subject a therapeutically effective amount of a therapeutic agent comprising a targeted inhibitor molecule comprising a targeting portion and an inhibitor portion, wherein the molecule inhibits complement, and wherein therapeutic agent is administered in combination with rehabilitation therapy or thrombolytic agent.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: May 18, 2021
    Assignees: MUSC Foundation For Research Development, United States Government as Represented by the Department of Veterans Affairs
    Inventors: Stephen Tomlinson, DeAnna Adkins, Ali Alawieh
  • COMPOSITIONS AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM INJURY
    Publication number: 20190247478
    Abstract: The present invention describes compositions and method for improving outcomes after injury to the central nervous system wherein complement signaling is activated. In one aspect, the method comprises administering to a subject a therapeutically effective amount of a therapeutic agent comprising a targeted inhibitor molecule comprising a targeting portion and an inhibitor portion, wherein the molecule inhibits complement, and wherein therapeutic agent is administered in combination with rehabilitation therapy or thrombolytic agent.
    Type: Application
    Filed: October 17, 2017
    Publication date: August 15, 2019
    Inventors: Stephen TOMLINSON, DeAnna ADKINS, Ali ALAWIEH